"10.1371_journal.pone.0126297","plos one","2015-05-14T00:00:00Z","Natalya Dinat; Edmore Marinda; Shirra Moch; Andrew S C Rice; Peter R Kamerman","Centre for Palliative Care, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa; School of Public Health, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa; Division of Pharmacology, School of Therapeutic Sciences, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa; Pain Research, Department of Surgery and Cancer, Imperial College London, London, United Kingdom; Pain Medicine, Chelsea and Westminster Hospital NHS Foundation Trust, London, United Kingdom; Brain Function Research Group, School of Physiology, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa","Conceived and designed the experiments: ND EM PRK. Performed the experiments: ND SM. Analyzed the data: EM PRK. Wrote the paper: ND EM SM ASCR PRK.","The following conflict of interest declarations were made by the authors: SM and EM have no declarations; ND and PRK have received honoraria from Pfizer Inc for educational activities; ASCR is a member of the Scientific Advisory Board of Spinifex Pharmaceuticals and throughout has been engaged on the non-clinical and clinical development of AT2 receptor antagonists, for which he is remunerated via Imperial College Consultants, has conducted contract pre-clinical efficacy research on the AT2 programme for which his laboratory at Imperial College received funding from Spinifex Pharmaceuticals, has share options in Spinifex Pharmaceuticals, undertakes consulting for Imperial College Consultants and in the past 36 months has received fees from Spinifex Pharmaceuticals, Astellas, Medivir, Servier and Allergan, has received consultancy fees from the Wellcome Trust Seeding Drug Discovery Committee, is a Principal Investigator in the European Union funded Private Public Partnership Innovative Medicines Initiative “EUROPAIN” – Joint Undertaking and a number of pharmaceutical companies are also engaged in that project, has received funding through EUROPAIN for research studentships from Pfizer and Astellas, has other recent or current grant/studentship funding from Wellcome Trust (London Pain Consortium), Dunhill Medical Trust, NC3Rs, Westminster Medical School Research Trust, International Association for the Study of Pain, National Institute of Academic Anaesthesia, Derek Butler Trust, Medical Research Council Industrial, Biotechnology and Biological Sciences Research Council and Pfizer/ Christian-Albrechts University of Kiel (Neuropain), and is a member of the England and Wales Joint Committee on Vaccination and Immunisation (Varicella sub-group). These declared conflicts of interest do not alter the authors' adherence to PLOS ONE policies on sharing data and materials.","2015","05","Natalya Dinat","ND",5,TRUE,3,2,2,5,TRUE,FALSE,FALSE,0,NA,FALSE
